Shares of Sangamo BioSciences (SGMO) jump 5.5% higher premarket after the firm announces results...

|About: Sangamo BioSciences, Inc. (SGMO)|By:, SA News Editor

Shares of Sangamo BioSciences (SGMO) jump 5.5% higher premarket after the firm announces results from a Phase 1 clinical program to develop a HIV/AIDS therapeutic treatment. "The data obtained in our treatment interruption studies are very exciting and represent significant progress toward a 'functional cure' for HIV/AIDS."